Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Estimate the Length of Gross Tumor in Patients With Squamous Cell Carcinoma of the Esophagus

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 136-141

  Zhong, Xiaojun ^a,b   Yu, Jinming ^b   Zhang, Baijiang ^b   Mu, Dianbin ^b   Zhang, Weidi ^b   Li, Daotang ^b   Han, Anqin ^b   Song, Pingping ^b   Li, Hui ^b   Yang, Guoren ^b   Kong, Feng Ming ^c   Fu, Zheng ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Esophageal carcinoma; Positron emission tomography; Radiotherapy

Indexed keywords

CORRELATION METHODS; DIAGNOSTIC RADIOGRAPHY; MEDICAL IMAGING; ONCOLOGY; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; TOMOGRAPHY; TUMORS;

CORRELATION COEFFICIENTS; ESOPHAGEAL CARCINOMA; ESOPHAGEAL CARCINOMATA; ESOPHAGEAL SQUAMOUS CELL CARCINOMATA; FDG PETS; FLUORODEOXYGLUCOSE; GROSS TUMOR VOLUMES; MEAN LENGTHS; OPTIMAL METHODS; OPTIMAL THRESHOLDS; PET DATUMS; PET SCANS; POSITRON EMISSIONS; RADICAL SURGERIES; SQUAMOUS CELL CARCINOMATA; STANDARD UPTAKE VALUES; STANDARDIZED UPTAKE VALUES; VISUAL INTERPRETATIONS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GROSS TUMOR LENGTH; HUMAN; HUMAN TISSUE; MALE; ONCOLOGICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; CANCER STAGING; COMPUTER ASSISTED DIAGNOSIS; ESOPHAGUS TUMOR; METHODOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57649112364     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.015     Document Type: Article

References (22)

1. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285 (2001) 914-924
2. Kato H., Miyazaki T., Nakajima M., et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 103 (2005) 148-156
3. Yu J., Yuan S., Yu Y., et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med 47 (2006) 1255-1259
4. Chang J.T., Chan S.C., Yen T.C., et al. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 62 (2005) 501-507
5. van Der Wel A., Nijsten S., Hochstenbag M., et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys 61 (2005) 649-655
6. Gondi V., Bradley K., Mehta M., et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 187-195
7. Koshy M., Paulino A.C., Howell R., et al. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 27 (2005) 494-502
8. Kiffer J.D., Berlangieri S.U., Scott A.M., et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19 (1998) 167-177
9. Leong T., Everitt C., Yuen K., et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78 (2006) 254-261
10. Konski A., Doss M., Milestone B., et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1123-1128
11. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
12. Mah K., Caldwell C.B., Ung Y.C., et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
13. Nestle U., Kremp S., Schaefer-Schuler A., et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 46 (2005) 1342-1348
14. Hicks R.J., and Mac Manus M.P. 18F-FDG PET in candidates for radiation therapy: Is it important and how do we validate its impact?. J Nucl Med 44 (2003) 30-32
15. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
16. Biehl K.J., Kong F.M., Dehdashti F., et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: Is a single standardized uptake value threshold approach appropriate?. J Nucl Med 47 (2006) 1808-1812
17. Drudi F.M., Trippa F., Cascone F., et al. Esophagogram and CT vs endoscopic and surgical specimens in the diagnosis of esophageal carcinoma. Radiol Med (Torino) 103 (2002) 344-352
18. Lerut T., Flamen P., Ectors N., et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232 (2000) 743-752
19. Choi J.Y., Lee K.H., Shim Y.M., et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 41 (2000) 808-815
20. Ma G.W., Rong T.H., Long H., et al. [Shrinkage of resected specimens of esophageal carcinoma]. Ai Zheng 23 (2004) 193-195
21. Lam K.Y., Ma L.T., and Wong J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 49 (1996) 124-129
22. Yuasa N., Miyake H., Yamada T., et al. Prognostic significance of the location of intramural metastasis in patients with esophageal squamous cell carcinoma. Langenbecks Arch Surg 389 (2004) 122-127